Search

Your search keyword '"Rei GOTO"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Rei GOTO" Remove constraint Author: "Rei GOTO"
165 results on '"Rei GOTO"'

Search Results

51. Comment on 'Health and Public Health Implications of <scp>COVID</scp> ‐19 in Asian Countries'

52. Geographical accessibility to gambling venues and pathological gambling: an econometric analysis of pachinko parlours in Japan

53. Nudging patients with chronic kidney disease at screening to visit physicians: A protocol of a pragmatic randomized controlled trial

54. Current treatment patterns and medical costs for multiple myeloma in Japan: a cross-sectional analysis of a health insurance claims database

55. Modeling and Suppression Method for Guided Mode in TC-SAW Devices

56. Spurious free TC-SAW duplexer using the SiO2/LiNbO3 structure

57. First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan

58. Economic Impacts of Smoking and Smoking Cessation

59. Potential capacity of endoscopic screening for gastric cancer in Japan

60. A socioeconomic and behavioral survey of patients with difficult-to-control type 2 diabetes mellitus reveals an association between diabetic retinopathy and educational attainment

61. Willingness to pay for QALY: perspectives and contexts in Japan

62. Estimating the Net Utility Gains Among Donors and Recipients of Adult Living Donor Kidney Transplant

63. PCV73 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS WARFARIN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION IN THE JAPANESE HEALTHCARE SETTING

64. From fragmentation toward integration: a preliminary study of a new long-term care policy in a fast-aging country

65. Influence of Japan’s 2004 postgraduate training on ophthalmologist location choice, supply and distribution

66. Why Screening Rates Vary between Korea and Japan-Differences between Two National Healthcare Systems

67. Attitudes towards passive smoking at restaurants and effects of the provision of information: A comparison between smokers and non-smokers via a web survey

68. Cost analysis of leuprorelin acetate in Japanese pre-menopausal breast-cancer patients: comparison between 6-month and 3-month depot formulations

69. Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations

70. Examining the association of smoking with work productivity and associated costs in Japan

71. Impact of improved price transparency on patients' demand of healthcare services

72. The modeling of the transverse mode in TC-SAW using SiO2/LiNbO3 structure

73. Analysis of the Evidence-practice Gap to Facilitate Proper Medical Care for the Elderly: Investigation, using Databases, of Utilization Measures for National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB)

74. Can economic-psychological parameters predict successful smoking cessation?

76. Multimode coupling of modes model for spurious responses on SiO2/LiNbO3 substrate

77. SIMULTANEOUS MEASUREMENT OF TIME AND RISK PREFERENCES: STATED PREFERENCE DISCRETE CHOICE MODELING ANALYSIS DEPENDING ON SMOKING BEHAVIOR

79. A cohort study to examine whether time and risk preference is related to smoking cessation success

80. Interdependency Among Addictive Behaviours and Time/Risk Preferences: Discrete Choice Model Analysis of Smoking, Drinking, and Gambling

82. Discrete choice experiment of smoking cessation behaviour in Japan

83. Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening

84. Study protocol of the TRICOLORE trial: A randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer

85. Behavioral economics survey of patients with type 1 and type 2 diabetes

86. Cost-Effectiveness Analysis of Smoking Cessation Interventions In Japan Using The Discrete Event Simulation Model

87. [Review of the health technology assessment on surgeries in Japan]

89. A SMARCB1-deficient vulvar neoplasm with prominent myxoid stroma: report of a case showing ERG and FLI1 expression

90. Evaluating the effect of Japan's 2004 postgraduate training programme on the spatial distribution of physicians

92. What is the most effective strategy for improving the cancer screening rate in Japan?

93. [Socioeconomic advantages of longer screening intervals for men with low prostate-specific antigen levels in prostate cancer mass screening]

94. Analysis of Defense Mechanisms against Bacterial Infection by Oral Streptococcus in Normal Flora

97. Productivity Loss of Cancer Patients in Japan

Catalog

Books, media, physical & digital resources